US3740421A
(en)
|
1966-09-19 |
1973-06-19 |
Basf Wyandotte Corp |
Polyoxyethylene-polyoxypropylene aqueous gels
|
DE3071552D1
(en)
|
1979-09-21 |
1986-05-22 |
Hitachi Ltd |
Semiconductor switch
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
US4950740A
(en)
|
1987-03-17 |
1990-08-21 |
Cetus Corporation |
Recombinant diphtheria vaccines
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
CA2063271A1
(en)
|
1989-07-14 |
1991-01-15 |
Subramonia Pillai |
Cytokine and hormone carriers for conjugate vaccines
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
ATE245446T1
(de)
|
1992-02-11 |
2003-08-15 |
Jackson H M Found Military Med |
Dualer träger für immunogene konstrukte
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
JP3506431B2
(ja)
|
1992-05-06 |
2004-03-15 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ジフテリア毒素受容体結合領域
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
DE69434079T2
(de)
|
1993-03-05 |
2005-02-24 |
Wyeth Holdings Corp. |
Plasmid zur Herstellung von CRM-Protein und Diphtherie-Toxin
|
AU678613B2
(en)
|
1993-09-22 |
1997-06-05 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
|
US6455673B1
(en)
|
1994-06-08 |
2002-09-24 |
President And Fellows Of Harvard College |
Multi-mutant diphtheria toxin vaccines
|
US5917017A
(en)
|
1994-06-08 |
1999-06-29 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines bearing a mutated R domain
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
ATE241384T1
(de)
|
1995-03-22 |
2003-06-15 |
Jackson H M Found Military Med |
Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
|
EP0776216A1
(en)
|
1995-06-06 |
1997-06-04 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
EP1770164B1
(en)
|
1996-10-31 |
2010-09-01 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae antigens and vaccines
|
KR19980067137A
(ko)
|
1997-01-31 |
1998-10-15 |
박원훈 |
알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
BR0009163A
(pt)
|
1999-03-19 |
2001-12-26 |
Smithkline Beecham Biolog |
Vacina
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ, インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンaタンパク質キャリア
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
IL153558A0
(en)
|
2000-06-20 |
2003-07-06 |
Shire Biochem Inc |
Streptococcus antigens
|
AU8189501A
(en)
|
2000-06-29 |
2002-01-08 |
Smithkline Beecham Biolog |
Vaccine composition
|
DE60144198D1
(de)
|
2000-12-28 |
2011-04-21 |
Wyeth Llc |
Rekombinantes schutzprotein aus streptococcus pneumoniae
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
WO2003009869A1
(en)
|
2001-07-26 |
2003-02-06 |
Chiron Srl. |
Vaccines comprising aluminium adjuvants and histidine
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
WO2003054007A2
(en)
|
2001-12-20 |
2003-07-03 |
Shire Biochem Inc. |
Streptococcus antigens
|
FR2850106B1
(fr)
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
ZA200506159B
(en)
|
2003-02-10 |
2006-10-25 |
Elan Pharm Inc |
Immunoglobulin formulation and method of preparation thereof
|
AU2004219910B2
(en)
|
2003-03-13 |
2010-06-17 |
Glaxosmithkline Biologicals S.A. |
Purification process for bacterial cytolysin
|
CA2519511A1
(en)
|
2003-03-17 |
2004-09-30 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
AU2003901717A0
(en)
|
2003-04-10 |
2003-05-01 |
Western Sydney Area Health Service |
Identification of streptococcus pneumoniae serotypes
|
EP1781326A4
(en)
|
2004-06-04 |
2009-01-14 |
Pharmexa Inc |
INDUCTION OF AN IMMUNE RESPONSE AGAINST STREPTOCOKE PENUMONIA POLYSACCHARIDES
|
US20080219960A1
(en)
|
2004-12-16 |
2008-09-11 |
Masja Nathalie Nierop Groot |
Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
DK3466982T3
(da)
|
2005-04-08 |
2020-08-03 |
Wyeth Llc |
Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
KR101730748B1
(ko)
|
2005-04-08 |
2017-04-26 |
와이어쓰 엘엘씨 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7764278B2
(en)
|
2005-06-30 |
2010-07-27 |
Seiko Epson Corporation |
Integrated circuit device and electronic instrument
|
JO2813B1
(en)
|
2005-12-22 |
2014-09-15 |
جلاكسو سميث كلاين بايولوجيكالز اس.ايه |
A vaccine with multiple pneumococcal saccharides
|
DK1976974T3
(da)
|
2005-12-28 |
2014-09-15 |
Uab Research Foundation |
Pneumokok-serotyper.
|
JP5285431B2
(ja)
|
2005-12-28 |
2013-09-11 |
ザ ユーエイビー リサーチ ファウンデイション |
肺炎球菌血清型
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
WO2008021076A2
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Protein matrix vaccines and methods of making and administering such vaccines
|
AU2007307800C1
(en)
|
2006-10-10 |
2014-03-13 |
Wyeth Llc |
Purification of Streptococcus pneumoniae type 3 polysaccharides
|
DK2129693T3
(en)
|
2007-03-23 |
2017-02-13 |
Wyeth Llc |
BRIEF PURIFICATION PROCEDURE FOR THE PREPARATION OF STREPTOCOCCUS PNEUMONIAE-Capsule POLYACCHARIDES
|
PT2167121E
(pt)
|
2007-06-26 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae
|
US8540955B2
(en)
|
2007-07-10 |
2013-09-24 |
Wyeth Llc |
Process for producing aluminum phosphate
|
CN102257127B
(zh)
|
2008-12-18 |
2014-01-01 |
惠氏有限责任公司 |
使用二氧化碳控制肺炎链球菌多糖分子量的方法
|
DK2379734T3
(en)
|
2008-12-18 |
2018-04-23 |
Wyeth Llc |
Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
|
CN101590224A
(zh)
|
2009-06-30 |
2009-12-02 |
广州精达医学科技有限公司 |
高效14价肺炎球菌结合疫苗
|
EP2473188A4
(en)
|
2009-09-09 |
2014-01-01 |
Matrivax Res & Dev Corp |
PROTEIN MATRIX VACCINES WITH IMPROVED IMMUNOGENICITY
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
TW201136603A
(en)
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
CN102933229A
(zh)
|
2010-06-04 |
2013-02-13 |
惠氏有限责任公司 |
疫苗制剂
|
WO2012078482A1
(en)
|
2010-12-10 |
2012-06-14 |
Merck Sharp & Dohme Corp. |
Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions
|
CN102068690A
(zh)
|
2010-12-31 |
2011-05-25 |
北京民海生物科技有限公司 |
多价肺炎球菌荚膜多糖结合疫苗及其制备方法
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
CN103747798B
(zh)
|
2011-05-18 |
2018-10-26 |
马特里瓦克斯公司 |
包含聚阳离子的蛋白质基质疫苗组合物
|
US20140193876A1
(en)
|
2011-06-13 |
2014-07-10 |
Aaron R. Goerke |
Methods of purification of native or mutant forms of diphtheria toxin
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
CN103623401A
(zh)
|
2012-08-23 |
2014-03-12 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
CN103656631B
(zh)
|
2012-09-24 |
2015-08-19 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法
|
CN103656632B
(zh)
|
2012-09-24 |
2016-01-13 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖组合物、其制备方法及应用
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
EP3363806B1
(en)
|
2012-12-20 |
2022-11-16 |
Pfizer Inc. |
Glycoconjugation process
|
ITMI20130142A1
(it)
|
2013-01-31 |
2014-08-01 |
Biosynth Srl |
Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
|
CN104069488A
(zh)
|
2013-03-29 |
2014-10-01 |
北京科兴中维生物技术有限公司 |
多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
|
RU2743793C1
(ru)
|
2014-01-21 |
2021-02-26 |
Пфайзер Инк. |
Капсульные полисахариды Streptococcus pneumoniae и их конъюгаты
|
PE20212335A1
(es)
|
2014-01-21 |
2021-12-16 |
Pfizer |
Composiciones inmunogenicas que comprenden antigenos sacaridos capsulares conjugados y usos de los mismos
|
MX371454B
(es)
|
2014-01-21 |
2020-01-29 |
Pfizer |
Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
|
PT3244917T
(pt)
|
2015-01-15 |
2023-05-31 |
Pfizer |
Composições imunogénicas para utilização em vacinas pneumocócicas
|
MY182282A
(en)
|
2015-05-04 |
2021-01-18 |
Pfizer |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
BR112017026343A2
(pt)
|
2015-06-08 |
2019-11-19 |
Serum Inst Of India Private Ltd |
métodos para aperfeiçoar a adsorção de conjugados de proteína-polissacarídeo e formulação de vacina multivalente assim obtida
|
PT3313436T
(pt)
|
2015-06-23 |
2021-02-25 |
Biological E Ltd |
Vacina de conjugado pneumocócico multivalente
|
WO2017011338A1
(en)
|
2015-07-10 |
2017-01-19 |
President And Fellows Of Harvard College |
Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CA3138763A1
(en)
|
2015-11-17 |
2017-05-26 |
Pfizer, Inc. |
Media and fermentation methods for producing polysaccharides in bacterial cell culture
|
EP3377098A1
(en)
|
2015-11-20 |
2018-09-26 |
Pfizer Inc |
Immunogenic compositions for use in pneumococcal vaccines
|
US11058757B2
(en)
*
|
2016-03-31 |
2021-07-13 |
Pogona, LLC |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
US11191822B2
(en)
|
2016-06-22 |
2021-12-07 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
CN105999254A
(zh)
|
2016-06-27 |
2016-10-12 |
北京智飞绿竹生物制药有限公司 |
含2型和12f血清型的15价肺炎球菌结合物组合疫苗
|
WO2018009906A1
(en)
|
2016-07-08 |
2018-01-11 |
President And Fellows Of Harvard College |
Whole cell-protein conjugates and methods of making the same
|
CN109845298B
(zh)
|
2016-07-27 |
2021-12-28 |
夏普株式会社 |
使用系统信息值标签的无线电信方法和装置
|
CN109862908B
(zh)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
MX2019001341A
(es)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Composicion de conjugado de polisacarido neumococico multivalente-proteina.
|
KR101991457B1
(ko)
|
2016-09-06 |
2019-09-30 |
주식회사 엘지화학 |
다가 협막 다당류-운반 단백질을 포함하는 조성물 및 이의 용도
|
WO2018064444A1
(en)
|
2016-09-30 |
2018-04-05 |
Biological E Limited |
Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
|
KR20180043122A
(ko)
|
2016-10-19 |
2018-04-27 |
동국대학교 산학협력단 |
신규링커를 통한 폐렴구균 다당류-단백질 접합체 백신 및 이의 용도
|
KR102083973B1
(ko)
|
2016-10-28 |
2020-04-23 |
주식회사 엘지화학 |
향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도
|
CN108144056A
(zh)
|
2016-12-02 |
2018-06-12 |
武汉博沃生物科技有限公司 |
多价肺炎球菌多糖结合疫苗及其制备方法
|
WO2018134693A1
(en)
|
2017-01-20 |
2018-07-26 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
EP3576784A4
(en)
|
2017-01-31 |
2020-11-11 |
Merck Sharp & Dohme Corp. |
PROCESS FOR THE PRODUCTION OF POLYSACCHARIDE PROTEIN CONJUGATES
|
CN110225757A
(zh)
|
2017-01-31 |
2019-09-10 |
默沙东公司 |
由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
|
US20200061542A1
(en)
|
2017-02-24 |
2020-02-27 |
Merck Sharp & Dohme Corp. |
Methods for improving filterability of polysaccharide-protein conjugate reactions
|
WO2018156465A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Polysaccharide-protein conjugates utilizing diphtheria toxin fragment b as a carrier
|
MX2019009869A
(es)
|
2017-02-24 |
2019-10-02 |
Merck Sharp & Dohme |
Formulaciones de vacunas de conjugado de neumococos.
|
WO2018156491A1
(en)
|
2017-02-24 |
2018-08-30 |
Merck Sharp & Dohme Corp. |
Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
|
WO2018169303A1
(ko)
|
2017-03-15 |
2018-09-20 |
주식회사 엘지화학 |
다가 폐렴구균 백신 조성물
|
CN107929728A
(zh)
|
2017-04-19 |
2018-04-20 |
武汉博沃生物科技有限公司 |
一种肺炎球菌蛋白疫苗及其制备方法
|
AU2018280272C1
(en)
|
2017-06-10 |
2021-05-06 |
Inventprise, Inc. |
Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
|
CN109091668A
(zh)
|
2017-06-20 |
2018-12-28 |
浙江博和瑞达生物科技有限公司 |
16价肺炎链球菌结合疫苗组合物
|
WO2019036313A1
(en)
|
2017-08-16 |
2019-02-21 |
Merck Sharp & Dohme Corp. |
CONJUGATED PNEUMOCOCCAL VACCINE FORMULATIONS
|
CN117736348A
(zh)
|
2017-09-07 |
2024-03-22 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
KR20200051005A
(ko)
|
2017-09-07 |
2020-05-12 |
머크 샤프 앤드 돔 코포레이션 |
폐렴구균 폴리사카라이드 및 면역원성 폴리사카라이드-담체 단백질 접합체에서의 그의 용도
|
KR20200051004A
(ko)
|
2017-09-07 |
2020-05-12 |
머크 샤프 앤드 돔 코포레이션 |
폐렴구균 폴리사카라이드 및 면역원성 폴리사카라이드-담체 단백질 접합체에서의 그의 용도
|
EP3678694A4
(en)
|
2017-09-07 |
2021-10-20 |
Merck Sharp & Dohme Corp. |
METHOD FOR FORMULATING PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
|
EP3678653A4
(en)
|
2017-09-07 |
2021-05-26 |
Merck Sharp & Dohme Corp. |
ANTIPNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN POLYSACCHARIDE-CARRIER PROTEIN IMMUNOGENIC CONJUGATES
|
US20200330579A1
(en)
|
2017-10-04 |
2020-10-22 |
Liffey Biotech Limited |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
US20200325020A1
(en)
|
2017-10-25 |
2020-10-15 |
Merck Sharp & Dohme Corp. |
Adjuvanted vaccines
|
JP2019118051A
(ja)
|
2017-12-27 |
2019-07-18 |
株式会社デンソー |
表示処理装置
|
CN108159408A
(zh)
|
2017-12-29 |
2018-06-15 |
云南沃森生物技术股份有限公司 |
一种多价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
CN108245674A
(zh)
|
2018-01-18 |
2018-07-06 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合物组合疫苗的处方及其制备方法
|
CN108079286B
(zh)
|
2018-01-19 |
2020-07-31 |
云南沃森生物技术股份有限公司 |
一种13价肺炎球菌多糖-蛋白结合物组合物及其制备方法和应用
|
BR112020015696A2
(pt)
|
2018-02-05 |
2020-12-08 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
AU2019215212A1
(en)
|
2018-02-05 |
2020-07-23 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
CN111787944A
(zh)
|
2018-03-05 |
2020-10-16 |
武汉博沃生物科技有限公司 |
一种肺炎链球菌疫苗及其制备方法
|
CN111989114A
(zh)
|
2018-04-18 |
2020-11-24 |
Sk生物科学株式会社 |
肺炎链球菌的荚膜多糖以及其免疫原性缀合物
|
EP3787674A4
(en)
|
2018-04-30 |
2022-01-26 |
Merck Sharp & Dohme Corp. |
PROCESS FOR THE PRODUCTION OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CAPSULAR PROTEIN CONJUGATES FROM LYOSPHERES
|
JP7397000B2
(ja)
|
2018-04-30 |
2023-12-12 |
メルク・シャープ・アンド・ドーム・エルエルシー |
凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
|
WO2019212846A1
(en)
|
2018-04-30 |
2019-11-07 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
US20210236384A1
(en)
|
2018-05-07 |
2021-08-05 |
Meissner Filtration Products |
Lyophilization Bag
|
CN108339115B
(zh)
|
2018-05-11 |
2020-07-10 |
武汉博沃生物科技有限公司 |
使用重组载体蛋白的肺炎球菌联合疫苗及其制备方法
|
WO2019220304A1
(en)
|
2018-05-14 |
2019-11-21 |
Tergene Biotech Pvt. Ltd. |
15 valent pneumococcal polysaccharide conjugate vaccine
|
EP3801469A4
(en)
|
2018-06-07 |
2022-03-09 |
Merck Sharp & Dohme Corp. |
KIT OF CRITICAL REAGENTS IN THE FORM OF LYOSPHERES
|
CN108524926B
(zh)
|
2018-06-29 |
2021-06-29 |
康希诺生物股份公司 |
一种多价肺炎球菌结合疫苗的制剂组合及其应用
|
WO2020009462A1
(ko)
|
2018-07-06 |
2020-01-09 |
주식회사 유바이오로직스 |
다가 폐렴구균 다당체-단백질 접합체를 포함하는 면역원성 조성물, 및 이를 포함하는 폐렴구균에 의한 질환 예방 백신
|
CN108543066A
(zh)
|
2018-07-17 |
2018-09-18 |
成都安特金生物技术有限公司 |
一种24价肺炎球菌多糖疫苗及其鉴别方法
|
WO2020021416A1
(en)
|
2018-07-21 |
2020-01-30 |
Biological E Limited |
Vaccine formulations comprising preservative system
|
EP3852795A4
(en)
|
2018-09-23 |
2022-11-23 |
Biological E Limited |
PURIFIED CAPSULE POLYSACCHARIDES FROM STREPTOCOCCUS PNEUMONIAE
|
BR112021012521A2
(pt)
|
2018-10-12 |
2021-09-14 |
Biological E Limited |
Vacina conjugada de polissacarídeo-proteína pneumocócica multivalente
|
CN109336989B
(zh)
|
2018-10-22 |
2022-05-13 |
北京智飞绿竹生物制药有限公司 |
一种通过粘度控制制备肺炎球菌荚膜多糖的方法
|
CA3120922A1
(en)
|
2018-12-12 |
2020-06-18 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
AU2019401535B2
(en)
|
2018-12-19 |
2023-12-14 |
Merck Sharp & Dohme Llc |
Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
WO2020152706A1
(en)
|
2019-01-21 |
2020-07-30 |
Biological E Limited |
Multivalent pneumococcal conjugate vaccine compositions
|
WO2020157772A1
(en)
|
2019-01-28 |
2020-08-06 |
Biological E Limited |
Multivalent pneumococcal polysaccharide-protein conjugate vaccine compositions
|
CN109771640A
(zh)
|
2019-02-28 |
2019-05-21 |
北京智飞绿竹生物制药有限公司 |
多价肺炎球菌结合疫苗
|
WO2020208502A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
US20220233674A1
(en)
|
2019-06-05 |
2022-07-28 |
Merck Sharp & Dohme Corp. |
An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same
|
WO2020247301A1
(en)
|
2019-06-05 |
2020-12-10 |
Merck Sharp & Dohme Corp. |
Methods of treating patients with an immunogenic composition that protects against s. pneumoniae serotype 29
|
CN110302375A
(zh)
|
2019-06-27 |
2019-10-08 |
康希诺生物股份公司 |
一种糖缀合物及其用途
|
CN110365663A
(zh)
|
2019-06-28 |
2019-10-22 |
北京淇瑀信息科技有限公司 |
一种隔离集群之间的访问方法、装置及电子设备
|
TW202116352A
(zh)
|
2019-07-18 |
2021-05-01 |
南韓商賽特瑞恩股份有限公司 |
包含多價肺炎球菌多醣-蛋白共軛物的免疫組成物、醫藥組成物及其用途
|
WO2021021729A1
(en)
|
2019-07-31 |
2021-02-04 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
CN111821432B
(zh)
|
2020-08-05 |
2022-10-18 |
北京智飞绿竹生物制药有限公司 |
一种多价肺炎球菌结合疫苗
|